Date(s) - 02/25/2020 - 02/27/2020
The Food and Drug Administration (FDA) is announcing the following public workshop entitled “Evolving Role of Artificial Intelligence in Radiological Imaging.” The intent of this public workshop is to discuss emerging applications of Artificial Intelligence (AI) in radiological imaging including AI devices intended to automate the diagnostic radiology workflow as well as guided image acquisition. The purpose of the workshop is to work with interested stakeholders to identify the benefits and risks associated with use of AI in radiological imaging. We also plan to discuss best practices for the validation of AI-automated radiological imaging software and image acquisition devices. Validation of device performance with respect to the intended use is critical to assess safety and effectiveness.
This public workshop will be held on February 25, 2020 from 8:00 a.m. to 5:30 p.m. (EST) and February 26, 2020 from 9 a.m. to 4:30 p.m. (EST) at the following location:
Natcher Conference Center, Building 45
Ruth Kirschstein Auditorium
NIH Main Campus
National Institutes of Health, 9000 Rockville Pike, Bethesda MD 20892
Complete details: https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/public-workshop-evolving-role-artificial-intelligence-radiological-imaging-02252020-02262020